May 21, 2013
Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation.
April 9, 2013
Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
February 27, 2013
February 19, 2013
Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
January 30, 2013
Inflamax Research Introduces Electronic Patient Data Acquisition Tablet™ (ePDAT)™ for Real-Time PRO Data Collection
January 17, 2013
Inflamax Research announces the launch of its Next Generation Mobile Environmental Exposure Chamber™ for conduct of Allergy & Asthma Trials